GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $210,000 | -7.9% | 5,583 | 0.0% | 0.04% | -15.1% |
| Q2 2020 | $228,000 | +7.5% | 5,583 | 0.0% | 0.05% | -10.2% |
| Q1 2020 | $212,000 | -17.8% | 5,583 | +1.8% | 0.06% | +7.3% |
| Q4 2019 | $258,000 | +10.3% | 5,483 | 0.0% | 0.06% | +1.9% |
| Q3 2019 | $234,000 | +6.8% | 5,483 | 0.0% | 0.05% | +5.9% |
| Q2 2019 | $219,000 | +3.3% | 5,483 | +7.9% | 0.05% | 0.0% |
| Q1 2019 | $212,000 | -22.1% | 5,083 | -28.7% | 0.05% | -19.0% |
| Q4 2018 | $272,000 | +31.4% | 7,129 | +38.8% | 0.06% | +23.5% |
| Q2 2018 | $207,000 | +3.0% | 5,136 | 0.0% | 0.05% | 0.0% |
| Q1 2018 | $201,000 | -15.9% | 5,136 | -12.7% | 0.05% | -17.7% |
| Q3 2017 | $239,000 | -5.9% | 5,883 | 0.0% | 0.06% | -11.4% |
| Q2 2017 | $254,000 | – | 5,883 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |